Klarsen specializes in data marketing for customer winning and engagement. Thanks to its qualified data and proprietary technologies, it allows its customers to increase their marketing performance and net sales. Klarsen disposes of proprietary assets and qualified and reactive databases, in its network of partners and on its own.

Employees

Sector

IT Services & Consulting

More about the company

Income Statement and Estimates

More financial data

Market Closed - Deutsche Boerse AG Other stock markets 02:50:49 09/06/2026 pm IST			5-day change	1st Jan Change
0.4400 ^EUR	+1.85%		0.00%	-43.88%

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/25/30	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI

Market Cap	28.76L 32.85L 26.55L 24.79L 46.68L 31Cr 47.74L 3.2Cr 1.23Cr 15Cr 1.23Cr 1.21Cr 53Cr	P/E 2023	3.28x	P/E 2024	-86x
Enterprise Value	39.57L 45.19L 36.53L 34.11L 64.21L 43Cr 65.68L 4.4Cr 1.7Cr 21Cr 1.7Cr 1.66Cr 73Cr	EV / Sales 2023	1.67x	EV / Sales 2024	0.82x
Free-Float	98.11%	Yield 2023 *	-	Yield 2024	-

03/11	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2025	CI
30/25/30	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/24/16	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2024	CI
30/24/30	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2023	CI
15/24/15	Acticor Biotech Raises EUR8 Million to Fund Emergency Stroke Treatment Development	MT
07/23/07	Acticor Biotech’s Phase 2/3 Trial for Stroke Drug Combo on Track for 2024 Results	MT
27/23/27	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/23/28	Klarsen Reports Earnings Results for the Full Year Ended December 31, 2022	CI
09/23/09	Acticor Biotech Secures Funding Until November After EUR12 Million Equity Raise; Stock Sinks 17%	MT
23/22/23	Acticor Biotech Seeks To Meet With US FDA Over Phase 2/3 Study Of Stroke Drug	MT
14/22/14	Twitter to shut down newsletter product Revue next year	RE
06/22/06	Acticor Biotech Wins EU Health Agency Nod For Phase 2/3 Stroke Study Design	MT
06/22/06	Klarsen Reports Earnings Results for the Half Year Ended June 30, 2022	CI

03/03	Klarsen : ALKLA information relative au nombre total de droits de vote et d'actions composant le capital	PU
25/02	Klarsen : ALKLA-Information relative au nombre de droits de vote et actions composant le capital	PU
10/12	Klarsen : ALKLA-Attribution gratuite de BSA	PU
09/12	Klarsen : ALKLA-ACTIVITE 3T2025	PU
27/11	Klarsen : ALKLA-Résultat augmentation de capital	PU

Klarsen Share Price Deutsche Boerse AG

Stocks

4YA

FR0011038348

IT Services & Consulting

Valuation: Klarsen

Chart: Klarsen

Latest news : Klarsen

Press Releases: Klarsen

News in other languages: Klarsen

Quotes and Performance

Course Extremes

Managers and Directors: Klarsen

Other IT Services & Consulting

Financials

Company Profile

Income Statement and Estimates

09/06	Klarsen : ALKLA – Report des résultats trimestriels et date de publication des comptes annuels – 9 Juin 2026
01/06	Klarsen : Information réglementée – 2026
06/05	Klarsen : Report de la publication des comptes annuels 2025
05/05	Klarsen : ALKLA – Ouverture d’une procédure de redressement judiciaire auprès du Tribunal judiciaire de Strasbourg pour la filiale ITL – Soutien financier de l’actionnaire principal – 05 Mai 2026
05/05	KLARSEN : Ouverture d’une procédure de redressement judiciaire auprès du Tribunal judiciaire de Strasbourg pour la filiale ITL

1 day	+1.85%
Current month	-29.49%
1 month	-12.35%
3 months	-41.80%
6 months	-44.86%
Current year	-43.88%

1 month	0.43	0.5
Current year	0.2	1.07
1 year	0.2	1.07
3 years	0.2	3.83
5 years	0.2	3.83
10 years	0.2	4.14

Manager	Title	Age	Since
Brice Gazeau CEO	Chief Executive Officer	-	-
Patrice Coffe DFI	Director of Finance/CFO	57	01/07/2008
Jean-Pierre Domingo CTO	Chief Tech/Sci/R&D Officer	-	01/01/2013

Director	Title	Age	Since
Patrice Coffe BRD	Director/Board Member	57	14/06/2010
Gérard Parrou BRD	Director/Board Member	74	27/06/2014
Frédéric Bartoli BRD	Director/Board Member	-	23/03/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
KLARSEN	+1.85%	0.00%	-	-	14.36L
IBM	+2.35%	+10.22%	-5.69%	+107.37%	26TCr
SNOWFLAKE INC.	+1.08%	+11.06%	+12.46%	+43.17%	8.63TCr
TATA CONSULTANCY SERVICES LTD.	+0.15%	-1.28%	-39.03%	-34.76%	8.03TCr
ACCENTURE PLC	-3.29%	-0.07%	-58.27%	-59.54%	7.89TCr
RELX PLC	-0.13%	-0.72%	-40.09%	-9.58%	5.5TCr
INFOSYS LIMITED	-0.43%	-1.40%	-35.53%	-19.84%	4.47TCr
FUJITSU LIMITED	+2.63%	+2.24%	-5.17%	+77.70%	3.43TCr
HCL TECHNOLOGIES LIMITED	+0.15%	-2.59%	-36.03%	-5.80%	3.16TCr
NEC CORPORATION	+6.64%	+7.75%	-3.41%	+193.81%	3.11TCr
Average	+1.04%	-0.08%	-23.42%	+32.50%	7.75TCr
Weighted average by Cap.	+0.93%	+2.97%	-19.10%	+44.08%

	2023	2024
Net sales	50.26L 57.4L 46.4L 43.33L 81.56L 54Cr 83.42L 5.58Cr 2.16Cr 27Cr 2.16Cr 2.11Cr 93Cr	63.11L 72.08L 58.26L 54.41L 1.02Cr 68Cr 1.05Cr 7.01Cr 2.71Cr 34Cr 2.71Cr 2.65Cr 116.72Cr
Net income	27.51L 31.42L 25.39L 23.71L 44.64L 30Cr 45.66L 3.06Cr 1.18Cr 15Cr 1.18Cr 1.15Cr 51Cr	-47.76T -54.55T -44.1T -41.18T -77.51T -51.57L -79.28T -5L -2L -25.44L -2L -2L -88.34L
Net Debt	-6L -7L -6L -5L -10.3L -6.85Cr -10.53L -70.48L -27.21L -3.38Cr -27.21L -26.61L -12Cr	10.81L 12.34L 10L 9L 17.54L 12Cr 17.94L 1.2Cr 46.35L 5.76Cr 46.35L 45.34L 20Cr